000 01569 a2200421 4500
005 20250514195456.0
264 0 _c20040927
008 200409s 0 0 eng d
022 _a0008-6363
024 7 _a10.1016/j.cardiores.2004.05.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoshimizu, Taka-Aki
245 0 0 _aCarvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.
_h[electronic resource]
260 _bCardiovascular research
_cSep 2004
300 _a662-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic Antagonists
_xpharmacology
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCarbazoles
_xpharmacology
650 0 4 _aCarvedilol
650 0 4 _aCell Line
650 0 4 _aHumans
650 0 4 _aKidney
_xembryology
650 0 4 _aMitogen-Activated Protein Kinases
_xmetabolism
650 0 4 _aNorepinephrine
_xpharmacology
650 0 4 _aPhenylephrine
_xpharmacology
650 0 4 _aPropanolamines
_xpharmacology
650 0 4 _aProtein Binding
650 0 4 _aReceptors, Adrenergic, alpha-1
_xmetabolism
650 0 4 _aReceptors, Adrenergic, beta
_xmetabolism
650 0 4 _aStimulation, Chemical
700 1 _aTsujimoto, Gozoh
700 1 _aHirasawa, Akira
700 1 _aKitagawa, Yoko
700 1 _aTanoue, Akito
773 0 _tCardiovascular research
_gvol. 63
_gno. 4
_gp. 662-72
856 4 0 _uhttps://doi.org/10.1016/j.cardiores.2004.05.014
_zAvailable from publisher's website
999 _c15005580
_d15005580